Dean Kamen: The Simplicity of Invention vs. the Challenge of Innovation
The legendary engineer says innovation = idea + scale
Dean Kamen is striving to create a platform for startups set to change the landscape of biomanufacturing.
Over the last two decades, technology has allowed inventors to excel. However, Dean Kamen asserts that true innovation has stagnated. Known for inventions such as the portable insulin pump and the Segway, Kamen shares his vision for empowering innovators.
How has inventing changed since the 1990s?
Kamen notes that children today have access to technologies that allow them to create in synthetic biology, akin to how he used Tinkertoys and Erector Sets. While the innovative spirit thrives, few will bring pharmaceutical advancements to market quickly.
Can you clarify the distinction between invention and innovation?
Kamen explains that invention refers to creating a novel idea or process, made increasingly accessible by advancements such as 3D printing and simulation tools. Yet, however simpler inventions have become, achieving the scale necessary for innovation poses substantial challenges.
He cites examples in biotechnology where development is easier but obtaining regulatory approval remains complex, indicating a preference for investments in more conventional and less risky ventures.
What about AI’s role in inventing?
Kamen acknowledges AI’s value in data processing but clarifies that it does not spontaneously generate new creative ideas. Instead, it acts as a supporting tool.
How does Kamen harness AI for innovation?
He founded the Advanced Regenerative Manufacturing Institute (ARMI) to facilitate the large-scale production of human cells and organs. By utilizing AI, ARMI aims to streamline processes and innovate technologies for biomanufacturing.
Is ARMI designed to promote innovation?
Kamen asserts that ARMI’s focus is not on producing a single product but on developing foundational technologies to spur an entirely new industry aimed at making health care more affordable through innovations.